5-year efficacy and safety of secukinumab in patients with ankylosing spondylitis: end-of-study results from the phase 3 MEASURE 2 trial
Helena Marzo‐Ortega, Joachim Sieper, Alan Kivitz, Ricardo Blanco, Martin Cohen, Karel Pavelká, Eumorphia Maria Delicha, Anna Stefańska, Hanno B. Richards, Susanne Rohrer
Topics & Concepts
SecukinumabAnkylosing spondylitisMedicineMeasure (data warehouse)Clinical trialPhase (matter)Internal medicineRheumatoid arthritisComputer scienceData miningPhysicsQuantum mechanicsPsoriatic arthritisSpondyloarthritis Studies and TreatmentsRheumatoid Arthritis Research and TherapiesPsoriasis: Treatment and Pathogenesis